DELPHARMA
Board
1 directorDirector (not named in the articles)
in office according to the deed of 16-03-2020
term without a fixed end
listed in the 2025 annual accounts, filed on 25-08-2026
Mandates through the years
1 name, the dashed line is todayDirector (not named in the articles)
Boardmandate already running before its first mention
Mandates as a list
-
- Director (not named in the articles), since before 16-03-2020
Control
Capital
- Contribution
- €20,000
- Shares
- 200
- Contribution per share
- €100
- Equity per share
- €556 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 16-03-2020 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Moitié cédant moitié acquéreurs proportionnellement au nombre d'actions, partie la plus diligente”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Fourth Thursday of May at 19:00